Nadolol 59651-0252
Product NDC
59651-0252- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 29, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA201893
Need to source Nadolol? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nadolol | 80 mg/1 |
Drug Class
beta-Adrenergic Blocker [EPC]Adrenergic beta-Antagonists [MoA]beta-Adrenergic Blocker [EPC]
Packaging Options(1)
100 TABLET in 1 BOTTLE (59651-252-01)